Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma Academic Article uri icon

  •  
  • Overview
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Serrano Aybar, Pablo
  • Serrano, Pablo E
  • Herman, Joseph M
  • Griffith, Kent A
  • Zalupski, Mark M
  • Kim, Edward J
  • Bekaii-Saab, Tanios S
  • Ben-Josef, Edgar
  • Dawson, Laura A
  • Ringash, Jolie
  • Wei, Alice C

publication date

  • October 2014